| Name
|
Amylin, human amidated
|
| Code
|
|
| The alias
|
Amylin, human amidated
|
| Sequence (single letter abbreviation)
|
KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2?(C2&C7 bridge)
|
| Sequence (three-letter abbreviation)
|
H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2?(trifluoroacetate salt)(Cys2 and 7 bridge)
|
| A basic description
|
42-residue peptide believed to be the major subunit of the vascular and plaque filaments in individuals with Alzheimer's disease, elderly people and patients with Trisomy 21 (Down's Syndrome). Inactive control.
|
| solubility
|
|
| The molecular weight
|
3905.4
|
| Chemical formula
|
C165H263N51O55S2
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Amylins
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Cys2 and 7 bridge)
|